Loading clinical trials...

ATX Register Accolade Stem & Trident/Tritanium Cup With X3 Insert | Clinical Trials | Clareo Health

COMPLETEDNA

ATX Register Accolade Stem & Trident/Tritanium Cup With X3 Insert

THE ATX REGISTRY ATX Register Accolade Stem & Trident/Tritanium Cup With X3 Insert International Multicentre Surveillance Register

NCT02520544•Stryker Orthopaedics

View on ClinicalTrials.gov

Summary

The aim of this register is to determine the Accolade/Accolade II stem and Trident/Tritanium cup survivorship over years.

Detailed Description

This is a prospective international multicentre surveillance register. The aim of this register is to determine the Accolade/Accolade II stem and Trident/Tritanium cup survivorship over years. All institutions willing to participate to the register, able to recruit at least 20 patients (up to 100 patients)

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Male and non-pregnant female patients between 18-75 years of age.
•2. Patients requiring uncemented primary Total Hip Arthroplasty (THA), suitable for the use of the Accolade stem and Trident/Tritanium cup.
•3. Patients with a diagnosis of osteoarthritis (OA).
•4. Patients who understand the conditions of the study and are willing and able to comply with the post-operative scheduled clinical and radiographic evaluations and the prescribed rehabilitation.
•5. Patients who signed the Ethics Committee approved Informed Consent Form prior to surgery.

Exclusion Criteria

•1. Patients who require revision of a previously implanted hip prosthesis.
•2. Patients who had a THA on contralateral side within the last 6 months.
•3. Patients who had a THA on contralateral side more than 6 months ago and the rehabilitation period outcome was considered unsatisfactory or not good (Harris Hip Score \< 85).
•4. Patients who will need lower limb joint replacement for another joint within one year.
•5. Patients requiring bilateral hip replacement.
•6. Patients who have had a prior procedure of acetabular osteotomy.
•7. Patients with acute femoral fractures
•8. Obese patients where obesity is severe enough to affect subject's ability to perform activities of daily living (body mass index, kg/m2: BMI ≥ 35).
•9. Patients with active or suspected infection.
•10. Patients with malignancy - active malignancy.
+10 more criteria

Locations (8)

Ziekenhuis Netwerk Antwerpen

Antwerp, Belgium

St. Antonius Ziekenhuis

Nieuwegein, Utrecht, Netherlands

Amphia Ziekenhuis

Breda, Netherlands

Maatschap Orthopaedie Ikazia

Rotterdam, Netherlands

Orbis Medisch Concern

Sittard, Netherlands

Rijnstate Arnhem

Zevenaar, Netherlands

Skånevård Kryh Division Kirurgi och Ortopedkliniken Hässleholm

Hässleholm, Sweden

Harrogate and District NHS Foundation Trust

Harrogate, United Kingdom

Key Dates

Start Date

January 1, 2012

Primary Completion Date

November 12, 2024

Completion Date

November 12, 2024

Last Updated

January 26, 2026

Enrollment

472

ACTUAL participants

Conditions

Arthroplasty, Replacement, Hip

Interventions

Accolade stem

DEVICE

Accolade II stem

DEVICE

Trident/Tritanium cup

DEVICE

Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.

NCT05169229

Arthroplasty, Replacement, HipOsteoarthritis, Hip+2 more

View study

RECRUITINGNA

Low Concentration Local Anesthesia Fascia Iliaca Block for Total Hip Arthroplasty

NCT06102811

Arthroplasty, Replacement, Hip

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 26, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

ATX Register Accolade Stem & Trident/Tritanium Cup With X3 Insert

Inclusion Criteria

Exclusion Criteria

Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.

Low Concentration Local Anesthesia Fascia Iliaca Block for Total Hip Arthroplasty

Trident II Tritanium Acetabular Shell Outcomes Study

Multicentre Prospective Study to Evaluate Long-term Clinical Outcomes of the Sirius Cemented Femoral Stem

CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery

A Study of the Effect of a Nurse Navigator Program on High Risk Patients